Home » Stocks » Adicet Bio

Adicet Bio, Inc. (ACET)

Stock Price: $12.53 USD -0.33 (-2.57%)
Updated Oct 23, 2020 3:25 PM EDT - Market open

Stock Price Chart

Key Info

Market Cap 245.46M
Revenue (ttm) 4.39M
Net Income (ttm) -65.98M
Shares Out 19.59M
EPS (ttm) -1.97
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 23, 2020
Last Price $12.53
Previous Close $12.86
Change ($) -0.33
Change (%) -2.57%
Day's Open 13.00
Day's Range 12.15 - 13.37
Day's Volume 68,363
52-Week Range 6.02 - 69.16

More Stats

Market Cap 245.46M
Enterprise Value 174.33M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 19.59M
Float 17.27M
EPS (basic) -13.44
EPS (diluted) -1.97
FCF / Share -13.04
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 134,556
Short Ratio 0.33
Short % of Float 0.78%
Beta n/a
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 55.95
PB Ratio 3.47
Revenue 4.39M
Operating Income -67.63M
Net Income -65.98M
Free Cash Flow -67.90M
Net Cash 71.13M
Net Cash / Share 3.63
Gross Margin 22.68%
Operating Margin -1,541.58%
Profit Margin n/a
FCF Margin -1,547.82%
ROA n/a
ROE n/a
ROIC -179.00%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (2)

Buy 2
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

(15.72% upside)
Current: $12.53
Target: 14.50
*Average 12-month price target from 2 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Operating Income-85.46-39.71-18.88
Net Income-82.74-37.61-33.78
Shares Outstanding4.903.780.57
Earnings Per Share-16.87-9.94-58.94
Operating Cash Flow-73.68-35.45-10.99
Capital Expenditures-0.27-0.36-0.04
Free Cash Flow-73.95-35.81-11.03
Cash & Equivalents91.7210853.35
Net Cash / Debt91.7210853.35
Book Value81.70104-31.93
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Adicet Bio, Inc.
Country United States
Employees 69
CEO Chen Schor

Stock Information

Ticker Symbol ACET
Stock Exchange NASDAQ
Sector Health Technology
Industry Biotechnology
Unique Identifier NASDAQ: ACET


Adicet Bio, a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors or T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and improve persistence for durable activity in patients. Its products pipeline includes ADI-001, which is in Phase 1 clinical study to treat non-Hodgkin's lymphoma; and ADI-002 that is in Phase 1 clinical study for the treatment of hepatocellular carcinoma and other solid tumors. The company is based in Menlo Park, California.